The exposure of rats to 10% flaxseed (FS) or an equivalent level of its major lignan, secoisolariciresinol diglucoside (SDG), during suckling enhances mammary gland differentiation, which protects against mammary carcinogenesis at adulthood. We determined whether this diet-induced mammary gland differentiation is mediated through the estrogenic pathway via epidermal growth factor receptor (EGFR) and estrogen receptor (ER) signaling. Rats were fed the AIN-93G basal diet (BD) from day 7 of pregnancy until delivery and then randomized to consume BID, FS, or SDG during lactation. After weaning, female offspring were fed BD throughout the experiment. At postnatal day (PND) 21 and the proestrus phase on PND 49-51, mammary glands of offspring were analyzed for morphology, cell proliferation, and expression of EGFR, epidermal growth factor (EGF), transforming growth factor-α, ER-α, and ER-ß. At PND 21, compared with the BD control, the number of terminal end buds (TEBs) and terminal ducts were increased by FS, whereas mammary epithelial cell proliferation was increased by both FS and SDG, suggesting that mammary morphogenesis was enhanced. Epithelial EGFR and stromal fibroblast EGF were increased by SDG, whereas epithelial ER-ß was decreased by FS. Conversely, at PND 49-51, a lower number of TEBs but a higher ratio of lobules to TEBs with decreased expression of EGFR or EGF was observed in both treatment groups. EGFR expression was positively associated with EGF expression and cell proliferation in TEB epithelium at PND 21. Urinary lignans of lactating dams were related to their offspring's indices of mammary gland development. In conclusion, exposure to FS or SDG during suckling enhanced mammary gland morphogenesis by modulation of EGFR and ER signaling, which led to more differentiated mammary glands at PND 49-51. The physiological outcomes of FS and SDG were similar, which suggests that SDG is partly responsible for the mammary gland differentiation effect.
RussoJRussoIH. Hormonally induced differentiation: a novel approach to breast cancer prevention. J Cell Biochem22:58–64, 1995.
2.
SivaramanLMedinaD. Hormone-induced protection against breast cancer. J Mamm Gland Biol Neoplasia7:77–92, 2002.
3.
Hilakivi-ClarkeLChoEdeAssisSOlivoSEalleyEBoukerKBWelchJNKhanGClarkeRCabanesA. Maternal and prepubertal diet, mammary development and breast cancer risk. J Nutr131: 154S–157S, 2001.
4.
GuzmanRCYangJRajkumarLThordasonGChenXNandiS. Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci U S A96:2520–2525, 1999.
5.
SivaramanLStephenLCMarkaverichBMClarkJAKrnacikSConneelyOMO'malleyBWMedinaD. Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats. Carcinogenesis19:1573–1581, 1999.
6.
FritzWACowardLWangJLamartiniereCA. Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in rats. Carcinogenesis19:2151–2158, 1998.
7.
Hilakivi-ClarkeLOnojafeIRaygadaMChoESkaarTRussoIClarkeR. Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br J Cancer80:1682–1688, 1999.
8.
LamartiniereCACotroneoMSFritzWAWangJMentor-MarcelRElgavishA. Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J Nutr132: 552S–558S, 2002.
9.
RussoJRussoIH. DNA labeling index and structure of the rat mammary gland as determinants of susceptibility to carcinogenesis. S Natl Cancer Inst61:1451–1495, 1978.
10.
RussoJWilgusGRussoIH. Susceptibility of the mammary gland to carcinogenesis: I. Differentiation of the mammary gland as determinant of tumor incidence and type of lesion. Am J Pathol96:721–736, 1979.
11.
RussoJRussoIH. Biology of Disease: biological and molecular bases of mammary carcinogenesis. Lab Invest57:112–137, 1987.
12.
ThompsonLURobbPSerrainoMCheungF. Mammalian lignan production from various foods. Nutr Cancer16:43–52, 1991.
13.
AxelsonMSjovallJGustafssonBESetchellKD. Origin of lignans in mammals and identification of a precursor from plants. Nature298:659–660, 1982.
14.
SathyamoorthyNWangTTYPhangTM. Stimulation of pS2 expression by diet-derived compounds. Cancer Res54:957–961, 1994.
15.
WangCKurzerMS. Effects of phytoestrogens on DNA synthesis in MCF-7 cells in the presence of estradiol or growth factors. Nutr Cancer31:90–100, 1998.
16.
TouJCChenJThompsonLU. Flaxseed and its lignan precursor, secoisolariciresinol diglycoside, affect pregnancy outcome and reproductive development in rats. J Nutr128:1861–1868, 1998.
17.
TouJCThompsonLU. Exposure to flaxseed or its lignans component during different developmental stages influences rat mammary gland structures. Carcinogenesis20:1831–1835, 1999.
18.
TouJCChenJThompsonLU. Dose, timing, and duration of flaxseed exposure affect reproductive indices and sex hormone levels in rats. J Toxicol Environ Health A56:555–570, 1999.
19.
AdlercreutzH. Phyto-oestrogens and cancer. Lancet Oncol3:364–373, 2002.
20.
ThompsonLU. Flaxseed, lignans, and cancer. In: ThompsonLUCunnaneSC, eds. Flaxseed in Human Nutrition (2nd ed.). Champaign, IL: AOCS Press, pp 194–222, 2003.
21.
PrazierALRyanCTRockettHWillettWCColditzGA. Adolescent diet and risk of breast cancer. Breast Cancer Res5: R59–R64, 2003.
22.
WardWEJiangFOThompsonLU. Exposure to flaxseed or purified lignan during lactation influences rat mammary gland structures. Nutr Cancer37:69–74, 2000.
23.
ChenJTanKPWardWEThompsonLU. Exposure to flaxseed or its purified lignan during suckling inhibits chemically induced mammary tumorigenesis. Exp Biol Med (Maywood)228:951–958, 2003.
24.
BrownNMWangJCotroneoMSZhaoYXLamartiniereCA. Prepubertal genistein treatment modulates TGF-α, EGF and EGF-receptor mRNAs and proteins in the rat mammary gland. Mol Cell Endocrinol144:149–165, 1998.
25.
CotroneoMSWangJFritzWAEltoumILamartiniereCA. Genistein action in the prepubertal mammary gland in a chemoprevention model. Carcinogenesis23:1467–1474, 2002.
26.
ImagawaWPedchenkoVKHelberJZhangH. Hormone/growth factor interactions mediating epithelial-stromal communication in mammary gland development and carcinogenesis. J Steroid Biochem Mol Biol80:213–230, 2002.
27.
ReevesPGNielsenFMFaheyGC. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr123:1239–1251, 1993.
28.
ThompsonLURickardSEOrchesonLJSeidlMM. Flaxseed and its lignans and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis17:1373–1376, 1996.
29.
Canadian Council on Animal Care. Guide to the Care and Use of Experimental Animals. Ottawa: Canadian Council on Animal Care, 1984.
30.
FoleyJTonTMaronpotRButterworthBGoldsworthyTL. Proliferating cell nuclear antigen (PCNA): comparison to tritiated thymidine (3H-TdR) as a marker of proliferating hepatocytes in rats. Environ Health Prospect101:199–205, 1993.
31.
OdumJPyrahITGFosterJRVan MillerJPJoinerRLAshbyJ. Comparative activities of p-nonylphenol and diethylstilbestrol in noble rat mammary gland and uterotrophic assays. Reg Toxicol Pharmacol29:184–195, 1999.
32.
BrownNLamartiniereCA. Xenoestrogens alter mammary gland differentiation and cell proliferation in the rat. Environ Health Perspect103:708–713, 1995.
33.
HarveyJMClarkGMOsborneCKAlliedD. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol17:1474–1481, 1999.
34.
ChenJStavroMThompsonLU. Dietary flaxseed inhibits human breast cancer growth and metastasis and down-regulates expression of insulin-like growth factor and epidermal growth factor receptor. Nutr Cancer43:187–192, 2002.
35.
KleerCGWojnoKJFieldsKSingletonTP. Detection of estrogen receptor of the breast using automated immunohistochemistry. Appl Immunohistochemistry Mol Morphol7:103–107, 1999.
36.
WardWEChenJThompsonLU. Exposure to flaxseed or its lignan during suckling only or continuous does not alter reproductive indices in male and female offspring. J Toxicol Environ Health A64:567–577, 2001.
37.
HiroiHInoueSWatanabeTOrimoAMomoedaMTsutsumiOMuramatsuM. Differential immunolocalization of estrogen receptor α and ß in rat ovary and uterus. J Mol Endocrinol22:37–44, 1999.
38.
SaundersPTKMaguireSMGaughanJMillarMR. Expression of oestrogen receptor ß (ERß) in multiple rat tissues visualized by immunohistochemistry. J Endocrinol154:13–16, 1997.
39.
KuiperGGJMLemmenJGCarlssonBCortonJCSafeSHVan der SaagPTVan der BurgBGustaffsonJ-A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology139:4252–4263, 1998.
40.
SaarinenNMWarriAMakelaSIEckermanCReunanenMAhotupaMSalmiSMFrankeAAKangasLSanttiR. Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies).Nutr Cancer36:207–216, 2000.
41.
SajiSJensenEVNilssonSRylanderTWarnerMGustafssonJ-A. Estrogen receptors α and ß in the rodent mammary gland. Proc Natl Acad Sci U S A97:337–342, 2000.
42.
SajiSSakaguchiHAnderssonSWarnerMGustafssonJ-A. Quantitative analysis of estrogen receptor proteins in rat mammary gland. Endocrinology142:3177–3186, 2001.
43.
ForsterCMakelaSWarriAKietzSBeckerDHultenbyKWarnerMGustafssonJ-A. Involvement of estrogen receptor ß in terminal differentiation of mammary gland epithelium. Proc Natl Acad Sci USA99:15578–15583, 2002.
44.
ColemanSSilbersteinGBDanielCW. Ductal morphogenesis in the mouse mammary gland: evidence supporting a role of epidermal growth factor. Dev Biol127:304–315, 1988.
45.
SternDF. ErbBs in mammary development. Exp Cell Res284:89–98, 2003.
46.
ZhangZTengCT. Methoxychlor stimulates the mouse lactoferrin gene promoter through a GC-rich element. Biochem Cell Biol80:23–26, 2002.
47.
WiesenJFYoungPWerbZCunhaGR. Signaling through the stromal epidermal growth factor is necessary for mammary ductal development. Development126:335–344, 1999.
48.
SebastianJRichardsRGWalkerMPWiesenJFWerbZDerynckRHornYKCunhaGRDiAugustineRP. Activation and function of the epidermal growth factor receptor and erbB-2 during mammary gland morphogenesis. Cell Growth Diff9:777–785, 1998.
49.
MatsuiYHalterJTHoltJTHoganBLCoffeyRJ. Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice. Cell61:1147–1155, 1990.
50.
XieWPatersonAChinENabellLKudlowJ. Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development. Mol Endocrinol1:1766–1781, 1997.
51.
YangJYoshizawaKNandiSTsuburaA. Protective effects of pregnancy and lactation against N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats. Carcinogenesis20:623–628, 1999.
52.
ThompsonLU. Analysis and bioavailability of lignans. In: ThompsonLUCunnaneSC, eds. Flaxseed in Human Nutrition (2nd ed.). Champaign, IL: AOCS Press, pp 92–116, 2003.
53.
AdlercreutzHBannwartCWahalaKMakelaTBrunowGHaseTArosemenaPJKellisJTVickeryLE. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol44:147–153, 1993.
